Intuitive Surgical (NASDAQ:ISRG – Get Free Report)‘s stock had its “hold (c+)” rating reiterated by research analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.
ISRG has been the subject of a number of other research reports. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. UBS Group boosted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research report on Wednesday, July 23rd. Evercore ISI reduced their price target on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research report on Tuesday. Finally, Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 4th. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $589.43.
View Our Latest Report on ISRG
Intuitive Surgical Trading Up 1.6%
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company’s revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.78 earnings per share. On average, equities analysts forecast that Intuitive Surgical will post 6.43 EPS for the current year.
Insider Activity
In other news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in ISRG. Chilton Capital Management LLC raised its holdings in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares in the last quarter. Tobam raised its holdings in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. Elite Financial Inc. purchased a new position in Intuitive Surgical during the first quarter worth about $26,000. Kilter Group LLC purchased a new position in Intuitive Surgical during the second quarter worth about $27,000. Finally, LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical during the first quarter worth about $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- The Significance of Brokerage Rankings in Stock Selection
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- What Are Growth Stocks and Investing in Them
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.